Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | FKB238 |
Trade Name | |
Synonyms | HD204|BP102|SCT501 |
Drug Descriptions |
FKB238 is a biosimilar to Avastin (bevacizumab), which is a VEGFA targeted antibody (J Clin Oncol 35, 2017 (suppl; abstr e14007)). |
DrugClasses | VEGFA Antibody 4 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Carboplatin + FKB238 + Paclitaxel | Carboplatin FKB238 Paclitaxel | 0 | 1 |
FKB238 | FKB238 | 0 | 0 |